Agra MF, Freitas PF, Barbosa-Filho JM (2007). Synopsis of the plants known as medicinal and poisonous in Northeast of Brazil. Rev. Bras. Farmacogn. 17(1):114-140.

Achyut BR, Arbab AS (2016). Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer. Onco. Targets Ther. 9:1047-1055.

Arteaga CL, Carty-Dugger T, Moses HL, Hurd SD, Pietenpol JA (1993). Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ. 4(3):193-201.

Azevedo AP, Ferreira SCP, Guerra RMN, Nascimento FRF (2003). Efeito do tratamento com mesocarpo de Babassu sobre o edema de pata e mediadores da inflamação. Rev. Ciênc. Saude 5:21-28.

Baldez RN (2006). Análise da cicatrização do cólon com uso do extrato aquoso da Orbignya phalerata (Babaçu) em ratos. Acta Cir. Bras. 21(2):31-38.

Bradford MM (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7(72):248-254.

Coulie PG, Van den Eynde BJ, Van der Bruggen P, Boon T (2014). Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat. Rev. Cancer 14(2):135-146.

Crowther D, Wagstaff J (1983). Lymphocyte migration in malignant disease. Clin. Exp. Immunol. 51:413-420.

de Souza PA, Palumbo AJ, Alves LM, de Souza VP, Cabral LM, Fernandes PD, Takiya CM, Menezes FS, Nasciutti LE (2011). Effects of a nanocomposite containing Orbignya speciose lipophilic extract on Benign Prostatic Hyperplasia. J. Ethnopharmacol. 135(1):135-46.

de Sousa VP, Crean J, de Almeida Borges VR, Rodrigues CR, Tajber L, Boylan F, Cabral LM (2013). Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia. Int. J. Nanomed. 8(1):3129-3139.

Dimeloe S, Burgener AV, Graehlert J, Hess C (2016). T cell metabolism governing activation, proliferation and differentiation ;a modular view. Immunology 1:1-25.

Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956). Colorimetric method for determination of sugars and related substances. Anal. Chem. 28(3):350-356.

Edelman J, Jefford TG (1968). The mechanisim of fructosan metabolism in higher plants as exemplified in Helianthus tuberosus. New Phytol. 67(3): 517-531.

Fortes TS, Fialho EMS, Reis AS, Assunção AKM, Azevedo APS, Barroquiero ESB, Guerra RNM, Nascimento FRF (2009). Desenvolvimento do tumor de Ehrlich em camundongos após tratamento in vitro com mesocarpo de Babassu Mart. Rev. Ciênc. Saúde 11:101-105.

Guerra RN, Silva VM, Aaragão-França LS, Oliviera PR, Feitosa R, Nascimento FR, Pontes-De-Carvalho LC (2011). Babassu aqueous extract (BAE) as an adjuvant for T helper (Th)1-dependent immune responses in mice of a Th2 immune response-prone strain. Immunology 12(1):1.

Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG (2001). Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 131(11):2957-2962.

Khyati P (2012). A review on herbal immunoadjuvant. Int. J. Pharm. Life Sci. 3:1568-1576.

Klebanoff CA, Gattinoni L, Restifo NP (2006). CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol. Rev. 211(1): 214-224.

Koch J, Hau J, Christensen JP, Jensen HE, Handen MB, Rieneck K (2013). Immune cells from SR/CR mice induce the regression of established tumors in BALB/c and C57BL/6 mice. Plos. One 8(3):e59995.

Kudryashov V, Kim HM, Ragupathi G, Danishefsky SJ, Livingston PO, Lloyd KO (1998). Immunogenicity of synthetic conjugates of Lewis (y) oligosaccharide with proteins in mice: towards the design of anticancer vaccines. Cancer Immunol. Imunother. 45(6):281-286.

Lehrnbechter T, Koehl U, Wittekindt B, Bochennek K, Tramsen L, Klingebiel T, Chanock SJ (2008). Changes in host defense induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies. Lancet Oncol. 9(3):269-278.

Li P, Wang F (2015). Polysaccharides: Candidates of promising vaccine adjuvants. Drug Discov. Ther. 9(2):88-93.

Loose D, Van de Wiele C (2009). The immune system and cancer. Cancer Biother. Radiopharm. 24(3):369-376.

Ma J, Liu L, Che G, Yu N, Dai F, You Z (2010). The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 10(1):1.

Mandal-Ghosh I, Chattopadhyay U, Baral R (2007). Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen. Cancer Immun. 7(1):8.

Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25(12):677-686.

Menard S, Tagliabue E, Canevari S, Fossati G, Colnaghi MI (1983). Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res. 43(3):1295-1300.

Moretão MP, Buchi DF, Gorin PA, Iacomini M, Oliveria MBM (2003). Effect of an acidic heteropolysaccharide (ARAGAL) from the gum of Anadenanthera colurbina (Angico branco) on peritoneal macrophage functions. Immunol. Lett. 89(2):175-185.

Mosser DM (2003). The many faces of macrophage activation. J. Leukoc. Biol. 73(2):209-212.

Nascimento FR, Barroquiero ES, Azevedo APS, Lopes AS, Ferreira SC, Silva LA, Maciel MCG, Rodriguez D, Guerra RN (2006). Macrophage activation induced by Orbignya phalerata Mart. J. Ethnopharmacol. 103(1):53-58.

Nascimento FR, Barroquiero ES, Azevedo APS, Maciel MCG, Periera WS, Ferreira SC, Farias JC, Phinheiro MT, Silva LA, Guerra RN (2010). Differential effects of subcronic and chronic oral treatments with Orbignya phalerata Mart. mesocarp on the inflammatory response. Comp. Bioact. Nat. Prod. 5:267-281.

Ochsenbein AF, Sierro S, Odermatt B, Pericin M, Karrer U (2001). Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411(6841):1058-1064.

Ochsenbein AF (2002). Principles of tumor immunosurveillance and implications for immunotherapy. Nature 9(12):1043-1055.

Pessoa RS, França EL, Ribeiro EB, Lanes PK, Chaud NG, Moraes LC, Honorio-França AC (2014). Microemulsion of babassu oil as a natural product to improve human immune system function. Drug Des. Dev. Ther. 16(9):21-31.

Rennó MN, Barbosa GM, Zancan P, Veiga VF, Alviano CS, Sola-Penna M, Menezes FS, Holandino C (2008). Crude ethanol extract from babassu (Orbignya speciosa): cytotoxicity on tumoral and non-tumoral cell lines. An. Acad. Bras. Cienc. 80(3):467-476.

Richmond A, Su Y (2008). Mouse xenograft models vs GEM models for human cancer therapeutics. Dis. Model. Mech. 1(2):78-82.

Sachs DH (1995). The immunologic response to xenografts. ILAR J. 37(1):16-22.

Schunk MK, Macallum GE (2005). Applications and optimization of immunization procedures. ILAR J. 46(3):241-257.

Silva BP, Parente JP (2001). An anti-inflammatory and immunomodulatory polysaccharide from Orbignya phalerata. Fitoterapia 72(8):887-893.

Silva CE, Santos OJ, Ribas-Filho JM, Tabushi FI, Kume MH, Jukonis LB, Cella IF (2015). Effect of Carapa guianensis Aublet (Andiroba) and Orbignya phalerata (Babassu) in colonic healing in rats. Rev. Col. Bras. Cir. 42(6):399-406.

Souza MH, Monteiro CA, Figueredo PM, Nascimento FR, Guerra RN (2011). Ethnopharmacological use of babassu (Orbignya phalerata Mart) in communities of babassu nut breakers in Maranhão, Brazil. J. Ethnopharmacol. 133(1):1-5.

Sun XB, Matsumoto M, Yamada H (1992). Anti-ulcer activity and mode of action of the polysaccharide fraction from the leaves of Panax ginseng. Plant. Med. 58(5):432-435.

Um SH, Rhee DK, Pyo S (2002). Involvement of protein kinase C and tyrosin kinase in tumoricidal activation of macrophage induced by Streptococcus penumoniae type II capsular polysaccharide. Int. Immunopharmacol. 2(1):129-137.